You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 207631 - 207640 of 207731 results
  1. SBIR PHASE I TOPIC #446- DEVELOPMENT OF SENOTHERAPEUTIC AGENTS FOR CANCER TREATMENT

    SBC: ATUX ISKAY GROUP LLC            Topic: 446

    New therapeutic approaches are urgently required for the treatment of high-risk neuroblastoma where patient outcomes have shown no improvement over recent decades. Many of the agents currently used clinically to arrest cancer cell proliferation of neuroblastoma do so by inducing cellular senescence, or a quasi-senescent state, in which treated neuroblastoma tumors evade chemotherapy. Relapse and d ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  2. AUTOMATED DEIDENTIFICATION OF PATHOLOGY AND RADIOLOGY DATA

    SBC: IMPACT BUSINESS INFORMATION SOLUTIONS, INC.            Topic: 427

    The overall project objective is to optimize and automate the detection and redaction of PHI in radiology data (DICOM) and pathology data (Whole Slide Imaging - WSI) – both header metadata and “burned in” pixel data – thereby minimizing the need for human-in-the-loop review/manual redaction and maximizing deidentified data throughput. Impact Business Information Solutions, Inc (IBIS) has e ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  3. TOPIC 453: THE PERFECT MEDICAL ASSISTANT FOR CANCER PREVENTION WITHIN PRIMARY CARE

    SBC: SOAP, INC.            Topic: 453

    Cancer is the second leading and the most expensive cause of death in the United States. With more than 500 million visits a year made to primary care physicians, prevention and early detection of cancer by identification of at-risk individuals in the primary care selling can significantly reduce the cancer care and cost burden to individuals and society at large. The Perfect Medical Assistant™ ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  4. ARPA-H PHASE II SBIR AWARD, TOPIC 03- ROBOTICS FOR AUTONOMOUS SOFT TISSUE SURGERY TITLE: ADVANCED IMAGING AIDED AUTONOMOUS ROBOTIC CHOLECYSTECTOMY

    SBC: OPTOSURGICAL LLC            Topic: AH03

    This ARPA-H SBIR Phase II project aims to develop an 'autonomous' minimally invasive surgery approach, enhancing outcomes in procedures like laparoscopic cholecystectomy through advanced robotic tools and a 'smart' vision framework. The research team will explore whether the novel robotic platform can elevate the safety and efficiency of gallbladder removal surgery by integrating supervised autono ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  5. SBIR TOPIC #446 PHASE I-DEVELOPMENT OF SENOTHERAPEUTIC AGENTS FOR CANCER TREATMENT

    SBC: RIPTIDE THERAPEUTICS LLC            Topic: 446

    Cancer therapies that harness the immune system are best positioned to improve long-term survival, but current immunotherapeutics suffer from nonresponse, resistance, and toxicity. Thus, conventional therapies such as radiation remain the standard-of-care for most patients. A major drawback of radiation therapy (RT) is the creation of therapy induced senescent (TIS) cells that exhibit a pro-tumor ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  6. DEVELOPMENT OF DIGITAL SATIORX, A VERY LOW COST REMOTELY CONTROLLABLE DISPOSABLE MICRONEEDLE TRANSDERMAL DRUG DELIVERY DEVICE ABLE TO DELIVER ANY LIQUID FDA APPROVED TRANSDERMAL DRUG

    SBC: TRITON SYSTEMS, INC.            Topic: AH02

    Triton Systems Inc. will create a transdermal microneedle patch and portable on-body pump system for therapeutic drug delivery for cardiovascular disease management (CVD) and intervention. The device will offer the capability for real-time remote management of therapeutic dosages by medical staff through communication with patient-specific electronic health records (EHRs), while remaining HIPAA-co ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  7. TOPIC NUMBER: ARPA-H 05: SCALE-UP: TRANSITION DISRUPTIVE TECHNOLOGIES FROM PROOF-OF-CONCEPT PROTOTYPES TO COMMERCIALLY SCALABLE AND DEPLOYABLE TECHNOLOGIES

    SBC: BAYSPEC, INC.            Topic: AH05

    This project plans to design, optimize, test, and deliver two fully functional miniature, portable MALDI-2 imaging mass spectrometer (IMS) prototype systems capable of high-resolution imaging mass spectrometry. The miniaturized IMS will support a disruptive technology as a portable point-of-care clinical diagnostic. AX

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  8. DEVELOPMENT OF DIGITAL SATIORX, A VERY LOW COST REMOTELY CONTROLLABLE DISPOSABLE MICRONEEDLE TRANSDERMAL DRUG DELIVERY DEVICE ABLE TO DELIVER ANY LIQUID FDA APPROVED TRANSDERMAL DRUG

    SBC: SATIO INC            Topic: AH02

    The project plans to develop Digital SatioRx, a very low cost remotely controllable disposable microneedle transdermal drug delivery device able to deliver any liquid FDA-approved transdermal drug. Digital SatioRx's telemedicine-enabled (EHR-integrated), remotely activated, disposable design and unique delivery system will minimize infection risk and ensure administration of a reproducible drug do ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  9. TOPIC 423 (PHASE II): AN INTEGRATED MULTI-LEVEL DECISION SUPPORT PLATFORM TO ADDRESS PATIENT-CENTERED AND EVIDENCE-BASED SOCIAL DETERMINANTS OF HEALTH AMONG CANCER PATIENTS.

    SBC: PISTEVO DECISION LLC            Topic: 423

    A strong body of evidence suggests that addressing Social Determinants of Health (SDH) within healthcare systems advances cancer treatment adherence and reduces disparities in outcomes; however, few studies actually intervene and provide resources to meet cancer patients’ SDH. Integrating SDH with clinical information within operational Clinical Decision Support (CDS) systems built into Electron ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  10. ARPA-H-01 TOPIC: STREPAPP: DEEP LEARNING TO DIAGNOSE STREPTOCOCCAL PHARYNGITIS

    SBC: AUSCULTECH DX LLC            Topic: AH01

    This Phase II project is for the advancement of diagnostic capabilities for detecting Group A Streptococcus pharyngitis (GAS). The goals under the contract include a comprehensive and diverse database, multiple trained and optimized deep learning models deployable on a mobile device, FDA clearance for the algorithms, and the validation of the app's performance through clinical research. These achi ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government